PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ACTIVE ONCOLOGICAL DISEASE, RECEIVING MEDICAL ANTI-CANCER CHEMOTHERAPY IN OUTPATIENT CONDITIONS. ROLE OF APIXABAN-Reference-Cited by-同舟云学术

PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ACTIVE ONCOLOGICAL DISEASE, RECEIVING MEDICAL ANTI-CANCER CHEMOTHERAPY IN OUTPATIENT CONDITIONS. ROLE OF APIXABAN

Published:2020-01-15 Issue:2 Volume: Page:46-54
ISSN:2658-5952
Container-title:Atherothrombosis
language:
Short-container-title:Aterotromboz

Author:

Fedotkina Yu. A.¹^ORCID,Panchenko E. P.¹^ORCID

Affiliation:

1. Federal State Budgetary Organization «National Medical Research Center of Cardiology» of The Ministry of Healthcare of The Russian Federation

Publisher

Remedium, Ltd.

Reference40 articles.

1. Levitan N., Dowlati A., Remick S.C., et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;(78):285–91. doi: 10.1097/00005792-199909000-00001 .

2. Chew H.K., Wun T., Harvey D., et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;(166):458–64. doi: 10.1001/archinte.166.4.458.

3. Khorana A.A., Francis C.W., Culakova E., et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;(5):632–34. doi: 10.1111/j.1538-7836.2007.02374.x.

4. Heit J.A., Spencer F.A., White R.H. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;(41):3–14. doi: 10.1007/s11239-015-1311-6.

5. Timp J.F., Braekkan S.K., Versteeg H.H., et al. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;(122):1712–1723. doi: 10.1182/blood-2013-04-460121.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Justification of Choice of Thromboprophylaxis Method in Patients with High-Risk Surgical Profile: A Literature Review;I.P. Pavlov Russian Medical Biological Herald;2022-06-29